Lupin launches authorized generic of Pennsaid
Pennsaid is a skin-applied, nonsteroidal anti-inflammatory drug that is used for treating the pain of osteoarthritis of the knee(s).
Lupin is introducing an authorized generic of Horizon Pharma Therapeutics' Pennsaid (diclofenac sodium topical solution), 2% w/w.
Pennsaid is a nonsteroidal anti-inflammatory drug applied to the skin, used for treating the pain of osteoarthritis of the knee(s).
[Read more: Lupin receives FDA OK for generic Banzel]
Diclofenac sodium topical solution, 2% w/w had a market value of roughly $509 million, according to IQVIA October 2022 data.